Fullerton Fund Management CO Ltd. Bristol Myers Squibb CO Transaction History

Fullerton Fund Management CO Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $451,395 - $511,795	9,408 New	9,408 $510,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $209,343 - $245,218	-3,538 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $219,037 - $238,531	3,538 New	3,538 $236,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $183,613 - $208,067	-3,180 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $182,627 - $202,375	3,180 New	3,180 $192,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fullerton Fund Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Fullerton Fund Management CO Ltd. with notifications on news.